Pfizer, Inc.

Acceptable risks of treatments to prevent rheumatoid arthritis among first-degree relatives: demographic and psychological predictors of risk tolerance (2022) Simons G, Janssen EM, Veldwijk J, Disantostefano RL, Englbrecht M, Radawski C, Valor-Mendez L, et al. Journal article Inter-Reader Consistency and Exclusionary Findings During Radiographic Screening for Phase 3 Trials of Tanezumab in Patients With Osteoarthritis. (2022) Guermazi A, Roemer F, Kompel AJ, Diaz LE, Crema MD, Brown MT, Hickman A, et al. Journal article Safety and Efficacy of Pediatric Growth Hormone Therapy: Results From the Full KIGS Cohort (2022) Maghnie M, Ranke MB, Geffner ME, Vlachopapadopoulou E, Ibanez L, Carlsson M, Cutfield W, et al. Journal article Preferences for preventive treatments for rheumatoid arthritis: discrete choice survey in the UK, Germany and Romania (2022) Simons G, Veldwijk J, Disantostefano RL, Englbrecht M, Radawski C, Bywall KS, Mendez LV, et al. Journal article Magnetic Resonance Imaging-Defined Osteophyte Presence and Concomitant Cartilage Damage in Knees With Incident Tibiofemoral Osteoarthritis: Data From the Pivotal Osteoarthritis Initiative Magnetic Resonance Imaging Analyses Study (2022) Mackay J, Guermazi A, Kwoh CK, See PLP, Jarraya M, Li L, Hannon MJ, et al. Journal article Ovarian function in young patients (pts) treated with postneoadjuvant palbociclib (PAL) and endocrine therapy (ET) for hormone receptor (HR)-positive, HER2-negative early breast cancer (BC): Explorative analysis in Penelope-B (2022) Furlanetto J, Marme F, Thode C, Nekljudova V, Liu Y, Jimenez MM, Reimer T, et al. Conference contribution Association of C-reactive Protein and Partial Mayo Score With Response to Tofacitinib Induction Therapy: Results From the Ulcerative Colitis Clinical Program (2022) Dubinsky MC, Magro F, Steinwurz F, Hudesman DP, Kinnucan JA, Ungaro RC, Neurath M, et al. Journal article MRI UNDERESTIMATES PRESENCE AND SIZE OF KNEE OSTEOPHYTES USING CT AS A REFERENCE STANDARD (2022) Roemer F, Engelke K, Laredo JD, Li L, Guermazi A Conference contribution Ageing and interferon gamma response drive the phenotype of neutrophils in the inflamed joint (2022) Grieshaber-Bouyer R, Exner T, Hackert NS, Radtke FA, Jelinsky SA, Halyabar O, Wactor A, et al. Journal article Phase Ib/II Trial of Ribociclib in Combination with Binimetinib in Patients with NRAS-mutant Melanoma. (2022) Schuler M, Zimmer L, Kim KB, Sosman JA, Ascierto PA, Postow MA, De Vos FY, et al. Journal article